Victor Cristea - Search Results

Year	Number of Results
2003	1
2009	4
2010	2
2011	9
2012	3
2013	3
2014	3
2015	1
2016	3
2017	2
2020	2
2021	2
2022	1
2023	1
2024	1

1

An overview of the tumor microenvironment, from cells to complex networks (Review).

Farc O, Cristea V. Farc O, et al. Among authors: cristea v. Exp Ther Med. 2021 Jan;21(1):96. doi: 10.3892/etm.2020.9528. Epub 2020 Nov 26. Exp Ther Med. 2021. PMID: 33363607 Free PMC article. Review.

2

Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.

Braicu C, Burz C, Berindan-Neagoe I, Balacescu O, Graur F, Cristea V, Irimie A. Braicu C, et al. Among authors: cristea v. Gastroenterology Res. 2009 Aug;2(4):191-199. doi: 10.4021/gr2009.07.1304. Epub 2009 Jul 20. Gastroenterology Res. 2009. PMID: 27942274 Free PMC article. Review.

3

Novel cellular and molecular approaches to stratification and treatment of colorectal cancer.

Miron N, Susman S, Balacescu O, Buiga R, Berindan-Neagoe I, Cristea V, Balacescu L, Manolescu V, Ciuleanu TE. Miron N, et al. Among authors: cristea v. J Gastrointestin Liver Dis. 2012 Dec;21(4):413-21. J Gastrointestin Liver Dis. 2012. PMID: 23256125 Free article. Review.

4

Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises.

Bagacean C, Zdrenghea M, Tempescul A, Cristea V, Renaudineau Y. Bagacean C, et al. Among authors: cristea v. Immunotherapy. 2016 May;8(5):569-81. doi: 10.2217/imt-2015-0015. Immunotherapy. 2016. PMID: 27140410 Review.

5

Immunological approach of the challenges of the XXI century in celiac disease.

Samasca G, Lupan I, Deleanu D, Cristea V, Makovicky P. Samasca G, et al. Among authors: cristea v. Int Rev Immunol. 2014 Jan;33(1):3-8. doi: 10.3109/08830185.2013.797414. Epub 2013 Jun 14. Int Rev Immunol. 2014. PMID: 23768156 No abstract available.

6

Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate Treatment.

Braicu C, Burz C, Berindan-Neagoe I, Balacescu O, Tantau M, Cristea V, Irimie A. Braicu C, et al. Among authors: cristea v. Gastroenterology Res. 2009 Jun;2(3):132-140. doi: 10.4021/gr2009.06.1299. Epub 2009 May 20. Gastroenterology Res. 2009. PMID: 27933122 Free PMC article. Review.

7

A Group of Tumor-Suppressive micro-RNAs Changes Expression Coordinately in Colon Cancer.

Farc O, Budisan L, Berindan-Neagoe I, Braicu C, Zanoaga O, Zaharie F, Cristea V. Farc O, et al. Among authors: cristea v. Curr Issues Mol Biol. 2023 Jan 20;45(2):975-989. doi: 10.3390/cimb45020063. Curr Issues Mol Biol. 2023. PMID: 36826008 Free PMC article.

8

Early sepsis biomarkers and their relation to mortality.

Cioara A, Valeanu M, Todor N, Cristea V, Lupse M. Cioara A, et al. Among authors: cristea v. Rom J Anaesth Intensive Care. 2016 Oct;23(2):159-160. doi: 10.21454/rjaic.7518/232.psi. Rom J Anaesth Intensive Care. 2016. PMID: 28913490 Free PMC article. No abstract available.

9

A role for serum cytokines and cell adhesion molecules in the non-invasive diagnosis of colorectal cancer.

Farc O, Berindan-Neagoe I, Zaharie F, Budisan L, Zanoaga O, Cristea V. Farc O, et al. Among authors: cristea v. Oncol Lett. 2022 Jul 26;24(3):323. doi: 10.3892/ol.2022.13443. eCollection 2022 Sep. Oncol Lett. 2022. PMID: 35949613 Free PMC article.

10

Is interleukin-17 a proatherogenic biomarker?

Cătană CS, Cristea V, Miron N, Neagoe IB. Cătană CS, et al. Among authors: cristea v. Roum Arch Microbiol Immunol. 2011 Jul-Sep;70(3):124-8. Roum Arch Microbiol Immunol. 2011. PMID: 22570926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year